Nano-engineered flavonoids for cancer protection

作者: Pradyumna Kumar Mishra

DOI: 10.2741/4771

关键词: Cell signalingChemistryGene expressionEpigenetic ProfileEpigenomeBroad spectrumRegulatorEpigeneticsClinical settingsCell biologyGeneral Biochemistry, Genetics and Molecular BiologyGeneral Immunology and MicrobiologyGeneral Medicine

摘要: Diet and environment are two critical regulators that influence an individual's epigenetic profile. Besides the anterograde signaling, mitochondria act as a key regulator of alterations in cancer either by controlling concentration cofactors, activity vital enzymes or affecting transcription NF-kappaB associated signaling molecules. As modifications major drivers aberrant gene expression, designing novel nutri-epigenomic strategies to modulate reversible will be important for effective protection. In this regard, nutraceuticals such flavonoids holds significant promise epigenome through network interconnected anti-redox mechanisms. However, low solubility, rapid metabolism poor absorption gastrointestinal tract hinder their use clinical settings. Therefore, it is imperative develop nano-engineered systems which could considerably improve targeted delivery these bioactive compounds with better efficacy pharmacokinetic properties. Concerted efforts nano-engineering using polymer, lipid complexation based approaches provide successful bench-to-bedside translation broad spectrum anti-cancer agents.

参考文章(352)
Lin Shen, Jingwei Yu, Jing Gao, Tingting Wang, Synergistic inhibitory effect of wogonin and low-dose paclitaxel on gastric cancer cells and tumor xenografts. Chinese Journal of Cancer Research. ,vol. 25, pp. 505- 513 ,(2013) , 10.3978/J.ISSN.1000-9604.2013.08.14
Clarissa Gerhauser, Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges Topics in Current Chemistry. ,vol. 329, pp. 73- 132 ,(2012) , 10.1007/128_2012_360
ZENG Linchai, Study on anti-tumor effect of cyanidin-3-glucoside on ovarian cancer China Journal of Chinese Materia Medica. ,vol. 37, pp. 1651- ,(2012) , 10.4268/CJCMM20121131
Baijun Cheng, Shun Lu, Xinghao Ai, Yi Zhao, Yi Yang, Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis. International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 8453- 8461 ,(2014)
Iffet Sahin F, Darcansoy Iseri O, Yurtcu E, Effects of silymarin and silymarin-doxorubicin applications on telomerase activity of human hepatocellular carcinoma cell line HepG2. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. ,vol. 20, pp. 555- 561 ,(2015)
Hai-Tao Xu, Hong-Jian Liu, Jing-Jing Zhang, Qing-Guang Zhang, Xue-Jun Gao, Jian-Wei Liu, Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b. Die Pharmazie. ,vol. 70, pp. 256- ,(2015)
Jianfang Feng, Xiaonan Chen, Yuanyuan Wang, Yuwen Du, Qianqian Sun, Wenqiao Zang, Guoqiang Zhao, Myricetin inhibits proliferation and induces apoptosis and cell cycle arrest in gastric cancer cells. Molecular and Cellular Biochemistry. ,vol. 408, pp. 163- 170 ,(2015) , 10.1007/S11010-015-2492-1
Hun Min Song, Gwang Hun Park, Hyun Ji Eo, Jin Wook Lee, Mi Kyoung Kim, Jeong Rak Lee, Man Hyo Lee, Jin Suk Koo, Jin Boo Jeong, None, Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells Biomolecules & Therapeutics. ,vol. 23, pp. 339- 344 ,(2015) , 10.4062/BIOMOLTHER.2015.024
Soumya C. Iyer, Ashidha Gopal, Devaraj Halagowder, Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma Molecular and Cellular Biochemistry. ,vol. 407, pp. 223- 237 ,(2015) , 10.1007/S11010-015-2471-6